BioSpace News Archive

Business

US Bioservices Selected by Rigel Pharmaceuticals, Inc. to Dispense TAVALISSE™ (fostamatinib disodium hexahydrate) Tablets

New therapy FDA-approved for adult patients with chronic immune thrombocytopenia

June 18, 2018
·
6 min read
BioMidwest

Hygieia Announces Data From Clinical Trial Evaluating The d-Nav® Insulin Guidance Service To Be Presented at the American Diabetes Association’s Annual Scientific Sessions

Oral Presentation Will Highlight Efficacy and Safety of d-Nav Service Among People With Type 2 Diabetes Compared to Close Follow-up by Diabetes Specialists

June 18, 2018
·
2 min read
BioMidwest

NorthStar Medical Technologies Updates Progress on Actinium-225 Radioisotope Program

NorthStar Medical Technologies provided a progress update on its actinium-225 (Ac-225) radioisotope program.

June 18, 2018
·
7 min read
Pharm Country

Investments Into Cannabis Companies are Expected to Increase

According to a research report provided by Marijuana Business Daily, cannabis retail sales continue to grow year-over-year as new markets emerge and more states legalize medical and recreational cannabis.

June 18, 2018
·
11 min read
Business

CorePower Yoga Partners With Yoga Foster To Bring Yoga And Mindfulness To Kids Across The Country

Partnership Kicks Off On International Yoga Day With Donation-Based CorePower Yoga Classes Nationwide

June 18, 2018
·
3 min read
FDA

Arcuro Medical Receives FDA Regulatory Clearance

Arcuro Medical Ltd. announced that it received regulatory clearance from the United States Food and Drug Administration (FDA) for its SuperBall™ meniscus repair system.

June 18, 2018
·
2 min read
Genetown

Stealth BioTherapeutics Announces $100M Financings to Advance Clinical Development of Elamipretide and Pipeline

Financing raised in two convertible note rounds.

June 18, 2018
·
3 min read
Biotech Bay

Silk Road Medical Announces Key Events for Society for Vascular Surgery 2018 Vascular Annual Meeting

Silk Road Medical, Inc. announced key events at the upcoming Society for Vascular Surgery 2018 Vascular Annual Meeting (VAM)

June 18, 2018
·
3 min read
Drug Development

Cellerant Therapeutics, Inc. Presents Phase 2 Results Showing CLT-008 Significantly Reduces Risk of Infections in AML Patients Undergoing Standard Induction Chemotherapy

Cellerant Therapeutics, Inc. presented results from its randomized controlled Phase 2 clinical trial of CLT-008 (romyelocel-L, human myeloid progenitor cells), an off-the-shelf cell therapy which does not require HLA matching intended to prevent bacterial and fungal infections during neutropenia.

June 18, 2018
·
3 min read
Genetown

PAREXEL to Lead Discussions on Global Drug Development, Unveil New Industry Research at DIA Annual Meeting

PAREXEL International Corporation announced today that several of its experts will discuss key issues facing the industry at the 54th Drug Information Association (DIA) Annual Meeting

June 18, 2018
·
3 min read